Alkemist Labs earns ISO 17025:2017 certificate with the addition of CBD and terpene assays

Photo © iStockphoto.com/nicolas_

Alkemist Labs’ (Garden Grove, CA) ISO/IEC 17025:2017 accreditation from the American Association for Laboratory Accreditation (A2LA) has been renewed until Feb. 28, 2022. The accreditation scope includes Alkemist’s internally developed cannabinoids and terpenes assays. The company’s quality management system was assessed and reviewed, and its ability to perform specific identification, analysis, and testing was confirmed. 

“Having the CBD method and the new terpenes method included in this most recent accreditation further solidifies our standing as a hemp testing authority,” said Elan Sudberg, CEO of Alkemist Labs, in a press release. “And it’s important to note that the identification portion of the testing scope meets the A2LA P112 Flexible Scope Policy, confirming our ability to give accurate results without delay for some complicated material.”

As a result of completing A2LA’s evolution process, Alkemist Labs can perform tests on dietary supplements, crude plant matter, plant extracts, oils, raw materials, finished products, fungal, algal species, and cannabis.  

“Alkemist Labs was one of the first cannabis-testing laboratories accredited by A2LA back in 2015, demonstrating their dedication to quality testing in this evolving industry,” said Chris Gunning, A2LA General Manager of Accreditation Services, in a press release. “We are pleased to see them expanding their capabilities to greater serve the needs of the market in California.”